This session will provide an update on endocrine issues in cystic fibrosis (CF). Animal models will be presented to provide insight into the role of CFTR in CF bone disease. The applications DXA and new technologies in the assessment of bone in the clinical and research settings will be discussed. The role of diabetes in inflammation, lung disease and mortality will be reviewed.
Children's Hospital of Philadelphia